Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative

•Incidence of meningococcal disease is similar across the Asia–Pacific region.•The most prevalent serogroups of N. meningitidis are B, w and Y, with c also emerging.•Except for China and Australia, vaccination is not included in NIPs across the region.•Antibiotic resistance is an ongoing concern, wi...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infection 2020-11, Vol.81 (5), p.698-711
Main Authors: Aye, Aye Mya Min, Bai, Xilian, Borrow, Ray, Bory, Sotharith, Carlos, Josefina, Caugant, Dominique A., Chiou, Chien-Shun, Dai, Vo Thi Trang, Dinleyici, Ener Cagri, Ghimire, Prakash, Handryastuti, Setyo, Heo, Jung Yeon, Jennison, Amy, Kamiya, Hajime, Tonnii Sia, Loong, Lucidarme, Jay, Marshall, Helen, Putri, Nina Dwi, Saha, Senjuti, Shao, Zhujun, Sim, James Heng Chiak, Smith, Vinny, Taha, Muhamed-Kheir, Van Thanh, Phan, Thisyakorn, Usa, Tshering, Kinley, Vázquez, Julio, Veeraraghavan, Balaji, Yezli, Saber, Zhu, Bingqing
Format: Article
Language:English
Subjects:
Antibiotic resistance
Asia - epidemiology
Asia-Pacific
Bacterial meningitis
Bangladesh
Carriage
Conjugate vaccine
Emerging strains
High-risk groups
Humans
Immunization program
Meningococcal disease
Meningococcal Infections - epidemiology
Meningococcal Infections - prevention & control
Meningococcal Vaccines
Myanmar
Neisseria meningitidis
Polysaccharide vaccine
Refugees
Serogroup
Surveillance
Vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Incidence of meningococcal disease is similar across the Asia–Pacific region.•The most prevalent serogroups of N. meningitidis are B, w and Y, with c also emerging.•Except for China and Australia, vaccination is not included in NIPs across the region.•Antibiotic resistance is an ongoing concern, with non-susceptible strains emerging.•A number of countries have adopted whole genome sequencing in surveillance programs. The degree of surveillance data and control strategies for invasive meningococcal disease (IMD) varies across the Asia–Pacific region. IMD cases are often reported throughout the region, but the disease is not notifiable in some countries, including Myanmar, Bangladesh and Malaysia. Although there remains a paucity of data from many countries, specific nations have introduced additional surveillance measures. The incidence of IMD is low and similar across the represented countries (
ISSN:0163-4453
1532-2742
DOI:10.1016/j.jinf.2020.07.025